{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:04:37Z","timestamp":1789815877054,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["NO.ZK[2024]-192"],"award-info":[{"award-number":["NO.ZK[2024]-192"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["NO.ZK[2022]-433"],"award-info":[{"award-number":["NO.ZK[2022]-433"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010891","name":"Guizhou Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["2023]-01"],"award-info":[{"award-number":["2023]-01"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cellsig.2025.112032","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:36:23Z","timestamp":1753832183000},"page":"112032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Kindlin-1 promotes mitophagy by inhibiting PINK1 degradation to enhance hepatocellular carcinoma progression and modulates sensitivity to donafenib"],"prefix":"10.1016","volume":"135","author":[{"given":"Huaxing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangling","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.112032_bb0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112032_bb0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10360","key":"10.1016\/j.cellsig.2025.112032_bb0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112032_bb0025","first-page":"386","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112032_bb0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00280-006-0393-4","article-title":"Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models","volume":"59","author":"Chang","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112032_bb0035","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.cellsig.2025.112032_bb0040","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s40265-021-01603-0","article-title":"Donafenib: first approval","volume":"81","author":"Keam","year":"2021","journal-title":"Drugs"},{"issue":"27","key":"10.1016\/j.cellsig.2025.112032_bb0045","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.21.00163","article-title":"Donafenib versus sorafenib in first-line treatment of unresectable or metastatic hepatocellular carcinoma: a randomized, open-label, parallel-controlled phase II-III trial","volume":"39","author":"Qin","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0050","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/physrev.00005.2018","article-title":"Evolving and expanding the roles of mitophagy as a homeostatic and pathogenic process","volume":"99","author":"Gustafsson","year":"2019","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0060","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949097","article-title":"MITOL promotes cell survival by degrading parkin during mitophagy","volume":"22","author":"Shiiba","year":"2021","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112032_bb0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/emboj.2012.38","article-title":"Mitochondrial quality control: a matter of life and death for neurons","volume":"31","author":"Rugarli","year":"2012","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112032_bb0070","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","article-title":"Mitophagy in human health, ageing and disease","volume":"5","author":"Picca","year":"2023","journal-title":"Nat. Metab."},{"issue":"5674","key":"10.1016\/j.cellsig.2025.112032_bb0075","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112032_bb0080","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","article-title":"PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models","volume":"19","author":"Han","year":"2023","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112032_bb0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-020-01768-8","article-title":"Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent axis","volume":"39","author":"Wu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112032_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216405","article-title":"Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy","volume":"576","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13062-024-00459-0","article-title":"RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2","volume":"19","author":"Guo","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.cellsig.2025.112032_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216621","article-title":"Icaritin with autophagy\/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1\/parkin-mediated mitophagy in hepatocellular carcinoma","volume":"587","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"issue":"7097","key":"10.1016\/j.cellsig.2025.112032_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112032_bb0120","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1080\/15548627.2021.2024702","article-title":"Negative feedback system to maintain cell ROS homeostasis: KEAP1-PGAM5 complex senses mitochondrially generated ROS to induce mitophagy","volume":"18","author":"Zeb","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112032_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.devcel.2011.12.014","article-title":"Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase parkin","volume":"22","author":"Lazarou","year":"2012","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112032_bb0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddg097","article-title":"Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in kindler syndrome","volume":"12","author":"Jobard","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"20","key":"10.1016\/j.cellsig.2025.112032_bb0135","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2009-10-239269","article-title":"Kindlins in FERM adhesion","volume":"115","author":"Malinin","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/376609","article-title":"Loss of Kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes kindler syndrome","volume":"73","author":"Siegel","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"47","key":"10.1016\/j.cellsig.2025.112032_bb0145","doi-asserted-by":"crossref","first-page":"36082","DOI":"10.1074\/jbc.M606259200","article-title":"Kindlin-1 is a phosphoprotein involved in regulation of polarity, proliferation, and motility of epidermal keratinocytes","volume":"281","author":"Herz","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112032_bb0150","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1074\/jbc.M307978200","article-title":"The kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion","volume":"279","author":"Kloeker","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112032_bb0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/embor.2008.202","article-title":"Kindlins: essential regulators of integrin signalling and cell-matrix adhesion","volume":"9","author":"Larjava","year":"2008","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.30699\/ijp.2021.526950.2603","article-title":"Kindlin1 as a gender and location-specific diagnostic marker in gastric cancer patients","volume":"17","author":"Abbaszadegan","year":"2022","journal-title":"Iran. J. Pathol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112032_bb0165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/15384047.2020.1792218","article-title":"FERMT1 promotes gastric cancer progression by activating the NF-kappaB pathway and predicts poor prognosis","volume":"21","author":"Fan","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0170","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12903-021-01955-9","article-title":"FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K\/AKT signaling pathway","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Oral Health"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112032_bb0175","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1007\/s13277-015-3060-8","article-title":"Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance","volume":"36","author":"Ma","year":"2015","journal-title":"Tumour Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112032_bb0180","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","article-title":"CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma","volume":"18","author":"Yao","year":"2022","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0925-4439(03)00035-8","article-title":"URP1: a member of a novel family of PH and FERM domain-containing membrane-associated proteins is significantly over-expressed in lung and colon carcinomas","volume":"1637","author":"Weinstein","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"17","key":"10.1016\/j.cellsig.2025.112032_bb0190","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jnci\/djr290","article-title":"Role of the focal adhesion protein Kindlin-1 in breast cancer growth and lung metastasis","volume":"103","author":"Sin","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112032_bb0195","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/0008-5472.CAN-17-1518","article-title":"Kindlin-1 promotes pulmonary breast cancer metastasis","volume":"78","author":"Sarvi","year":"2018","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112032_bb0200","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/1078-0432.CCR-10-2552","article-title":"Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer","volume":"17","author":"Fan","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/genes14030734","article-title":"FERMT1 is a prognostic marker involved in immune infiltration of pancreatic adenocarcinoma correlating with m(6)A modification and necroptosis","volume":"14","author":"Wu","year":"2023","journal-title":"Genes (Basel)"},{"issue":"13","key":"10.1016\/j.cellsig.2025.112032_bb0210","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/onc.2016.339","article-title":"FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of beta-catenin transcriptional activity","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/15548627.2022.2112830","article-title":"Targeting mitophagy to promote apoptosis is a potential therapeutic strategy for cancer","volume":"19","author":"Tang","year":"2023","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112032_bb0220","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-18-1409","article-title":"Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer","volume":"9","author":"Humpton","year":"2019","journal-title":"Cancer Discov."},{"issue":"13","key":"10.1016\/j.cellsig.2025.112032_bb0225","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1245\/s10434-017-6096-8","article-title":"High expression of the mitophagy-related protein Pink1 is associated with a poor response to chemotherapy and a poor prognosis for patients treated with neoadjuvant chemotherapy for esophageal squamous cell carcinoma","volume":"24","author":"Yamashita","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112032_bb0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.201402104","article-title":"PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity","volume":"205","author":"Kane","year":"2014","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.celrep.2017.06.022","article-title":"The ubiquitination of PINK1 is restricted to its mature 52-kDa form","volume":"20","author":"Liu","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112032_bb0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.4815","article-title":"PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease","volume":"241","author":"Arena","year":"2017","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0245","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-022-29039-4","article-title":"Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia","volume":"13","author":"Anderson","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112032_bb0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41419-023-05711-5","article-title":"STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation","volume":"14","author":"Qin","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112032_bb0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-020-01029-3","article-title":"STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib","volume":"14","author":"Zheng","year":"2021","journal-title":"J. Hematol. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:36:44Z","timestamp":1778701004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825004474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"alternative-id":["S0898656825004474"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112032","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kindlin-1 promotes mitophagy by inhibiting PINK1 degradation to enhance hepatocellular carcinoma progression and modulates sensitivity to donafenib","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112032"}}